Immune thrombocytopenic purpura

Results: 50



#Item
31European Journal of Haematology[removed]–182)  ORIGINAL ARTICLE Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist

European Journal of Haematology[removed]–182) ORIGINAL ARTICLE Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist

Add to Reading List

Source URL: www.ouhsc.edu

Language: English - Date: 2011-02-21 15:38:49
32Journal of Thrombosis and Haemostasis, 4: 1664–1672  REVIEW ARTICLE Management of patients with refractory immune thrombocytopenic purpura

Journal of Thrombosis and Haemostasis, 4: 1664–1672 REVIEW ARTICLE Management of patients with refractory immune thrombocytopenic purpura

Add to Reading List

Source URL: www.ouhsc.edu

Language: English - Date: 2007-02-13 16:42:28
33Suggested Intervals between Administration of Antibody-Containing Products and Measles-Containing and Varicella-Containing Vaccines - Minnesota Dept. of Health

Suggested Intervals between Administration of Antibody-Containing Products and Measles-Containing and Varicella-Containing Vaccines - Minnesota Dept. of Health

Add to Reading List

Source URL: www.health.state.mn.us

Language: English - Date: 2012-07-05 10:11:43
34CSL Behring	[removed]Draft Labeling Text Immune Globulin Intravenous (Human), 10% Liquid, Privigen®

CSL Behring [removed]Draft Labeling Text Immune Globulin Intravenous (Human), 10% Liquid, Privigen®

Add to Reading List

Source URL: www.fda.gov

Language: English
35

PDF Document

Add to Reading List

Source URL: www.mstrust.org.uk

Language: English - Date: 2014-07-08 05:46:25
36

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
37DIC following Rho(D) IGIV Administration

DIC following Rho(D) IGIV Administration

Add to Reading List

Source URL: www.fda.gov

Language: English
38Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion r

Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion r

Add to Reading List

Source URL: www.fda.gov

Language: English
39Summary Basis for Regulatory Action

Summary Basis for Regulatory Action

Add to Reading List

Source URL: www.fda.gov

Language: English
402  GAMMAGARD S/D Immune Globulin Intravenous (Human) SOLVENT DETERGENT TREATED

2 GAMMAGARD S/D Immune Globulin Intravenous (Human) SOLVENT DETERGENT TREATED

Add to Reading List

Source URL: www.abopharmaceuticals.com

Language: English - Date: 2013-07-02 17:20:52